BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11278868)

  • 1. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland.
    Schroeder JA; Thompson MC; Gardner MM; Gendler SJ
    J Biol Chem; 2001 Apr; 276(16):13057-64. PubMed ID: 11278868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88.
    Kato K; Lillehoj EP; Park YS; Umehara T; Hoffman NE; Madesh M; Kim KC
    J Immunol; 2012 Feb; 188(4):2014-22. PubMed ID: 22250084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation.
    Schroeder JA; Masri AA; Adriance MC; Tessier JC; Kotlarczyk KL; Thompson MC; Gendler SJ
    Oncogene; 2004 Jul; 23(34):5739-47. PubMed ID: 15221004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis.
    Weinstein EJ; Leder P
    Cancer Res; 2000 Jul; 60(14):3856-61. PubMed ID: 10919660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis.
    Al Masri A; Gendler SJ
    Oncogene; 2005 Sep; 24(38):5799-808. PubMed ID: 15897873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mammary epithelial apoptosis and sustained phosphorylation of Akt/PKB in MMTV-IGF-II transgenic mice.
    Moorehead RA; Fata JE; Johnson MB; Khokha R
    Cell Death Differ; 2001 Jan; 8(1):16-29. PubMed ID: 11313699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cytoplasmic domain of MUC1 induces hyperplasia in the mammary gland and correlates with nuclear accumulation of β-catenin.
    Li Y; Yi H; Yao Y; Liao X; Xie Y; Yang J; Yan Z; Wang L; Lu S; Kuang Y; Gu M; Fei J; Wang Z; Huang L
    PLoS One; 2011 Apr; 6(4):e19102. PubMed ID: 21533058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. erbB-2 overexpression in human mammary epithelial cells confers growth factor independence.
    Ignatoski KM; Lapointe AJ; Radany EH; Ethier SP
    Endocrinology; 1999 Aug; 140(8):3615-22. PubMed ID: 10433219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of MUC1 in mammary tumors generated in a double-transgenic mouse expressing human MUC1 cDNA, under the control of 1.4-kb 5' MUC1 promoter sequence and the middle T oncogene, expressed from the MMTV promoter.
    Graham RA; Morris JR; Cohen EP; Taylor-Papadimitriou J
    Int J Cancer; 2001 May; 92(3):382-7. PubMed ID: 11291075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of MUC1 expression in human mammary cell lines by the c-ErbB2 and ras signaling pathways.
    Scibetta AG; Albanese I; Morris J; Cooper L; Downward J; Rowe PP; Taylor-Papadimitriou J
    DNA Cell Biol; 2001 May; 20(5):265-74. PubMed ID: 11410163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erb-B2 homodimerization inhibits MUC1 transcription in cultured human mammary epithelial cells.
    Canbay E
    Cell Biol Int; 2003; 27(6):477-81. PubMed ID: 12798775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
    Muthuswamy SK; Muller WJ
    Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion.
    Schroeder JA; Adriance MC; Thompson MC; Camenisch TD; Gendler SJ
    Oncogene; 2003 Mar; 22(9):1324-32. PubMed ID: 12618757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
    Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
    Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
    Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
    Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells.
    Piyush T; Chacko AR; Sindrewicz P; Hilkens J; Rhodes JM; Yu LG
    Cell Death Differ; 2017 Nov; 24(11):1937-1947. PubMed ID: 28731466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1 can interact with adenomatous polyposis coli in breast cancer.
    Hattrup CL; Fernandez-Rodriguez J; Schroeder JA; Hansson GC; Gendler SJ
    Biochem Biophys Res Commun; 2004 Apr; 316(2):364-9. PubMed ID: 15020226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network.
    Troyer KL; Lee DC
    J Mammary Gland Biol Neoplasia; 2001 Jan; 6(1):7-21. PubMed ID: 11467454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of GTP-binding proteins in reversing the antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells.
    Sylvester PW; Nachnani A; Shah S; Briski KP
    Asia Pac J Clin Nutr; 2002; 11 Suppl 7():S452-9. PubMed ID: 12492634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.